StaffOctober 30, 2018
CRx BIO is a researcher and developer of advanced cannabinoid-based therapeutic formulations Denver – October 30, 2018/AxisWire/ Nexien BioPharma, Inc. (OTC QB: NXEN) (“Nexien” or the “Company”) announced today that it has acquired Princeton, New Jersey based CRx Bio Holdings LLC (“CRx”). CRx is engaged in the research and development of advanced cannabinoid therapeutic formulations with […]
